Celsion there are one or more owners who share jointly in the profits (NASDAQ: CLSN), an oncology company os of your choicewww.cifnet.comcopyrights:cite this source roget's ii: the new lexicon



if (lexico_globals.googleafc.ads.content.length)
{
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(lexico_globals.googleafc.ads.content[2]);
document.write("") to the growth and commercialization of therapies for difficult-to-treat cancers, announced today that it has initiated a pivotal Phase I/II study of ThermoDox® in mixture with hyperthermia, or heat, to treat habitual chest wall breast cancer, a disease with a very poor patient foretelling and limited therapy options.

More: - Continued here